GlucoTrack (GCTK) Institutional Ownership $0.20 -0.03 (-11.75%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$0.19 -0.01 (-5.37%) As of 03/28/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for GlucoTrack (NASDAQ:GCTK)CurrentInstitutional OwnershipPercentage10.92%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$1.28MNumber ofInstitutional Sellers(last 12 months)0 Get GCTK Insider Trade Alerts Want to know when executives and insiders are buying or selling GlucoTrack stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Remove Ads GlucoTrack Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2025 XTX Topco Ltd85,394$32K0.0%N/A10.634% 2/12/2025 Geode Capital Management LLC112,787$42K0.0%+315.3%14.098% 11/10/2022 Boston Financial Mangement LLC26,372$51K0.0%N/A0.170% (Data available from 1/1/2016 forward)Remove Ads GCTK Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GCTK shares? During the previous two years, the following institutional investors and hedge funds held shares of GlucoTrack shares: Geode Capital Management LLC ($42K), XTX Topco Ltd ($32K).Learn more on GCTK's institutional investors. What percentage of GlucoTrack stock is owned by institutional investors? 10.92% of GlucoTrack stock is owned by institutional investors. Learn more on GCTK's institutional investor holdings. Which institutional investors have been buying GlucoTrack stock? The following institutional investors have purchased GlucoTrack stock in the last 24 months: Geode Capital Management LLC ($85.63K), and XTX Topco Ltd ($85.39K). How much institutional buying is happening at GlucoTrack? Institutional investors have bought a total of 171,020 shares in the last 24 months. This purchase volume represents approximately $1.28M in transactions. Related Companies BTCY Major Shareholders SSKN Major Shareholders IINN Major Shareholders NURO Major Shareholders WOK Major Shareholders PAVM Major Shareholders STRR Major Shareholders BSGM Major Shareholders MHUA Major Shareholders BLAC Major Shareholders This page (NASDAQ:GCTK) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersNew Pick (93% history of rising by May 8)We just posted a new recommendation. Keep in mind: You could have boosted the Netflix trade we issued to the p...InvestorPlace | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredPartner with Elon Musk on Project Colossus… Before May 1stEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredHuge Elon-backed AI rollout begins – buy these nine stocksIf you suspect Elon Musk has an ulterior motive for coming to Washington, D.C.... You're 100% correct. ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GlucoTrack, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GlucoTrack With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.